These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32789000)

  • 1. Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the
    Bhagwan JR; Collins E; Mosqueira D; Bakar M; Johnson BB; Thompson A; Smith JGW; Denning C
    F1000Res; 2019; 8():1911. PubMed ID: 32789000
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential Transgene Silencing of Myeloid-Specific Promoters in the
    Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
    Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases.
    Luo Y; Liu C; Cerbini T; San H; Lin Y; Chen G; Rao MS; Zou J
    Stem Cells Transl Med; 2014 Jul; 3(7):821-35. PubMed ID: 24833591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives.
    Oceguera-Yanez F; Kim SI; Matsumoto T; Tan GW; Xiang L; Hatani T; Kondo T; Ikeya M; Yoshida Y; Inoue H; Woltjen K
    Methods; 2016 May; 101():43-55. PubMed ID: 26707206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.
    Bhagwan JR; Mosqueira D; Chairez-Cantu K; Mannhardt I; Bodbin SE; Bakar M; Smith JGW; Denning C
    J Mol Cell Cardiol; 2020 Aug; 145():43-53. PubMed ID: 32531470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.
    Hong SG; Yada RC; Choi K; Carpentier A; Liang TJ; Merling RK; Sweeney CL; Malech HL; Jung M; Corat MAF; AlJanahi AA; Lin Y; Liu H; Tunc I; Wang X; Palisoc M; Pittaluga S; Boehm M; Winkler T; Zou J; Dunbar CE
    Mol Ther; 2017 Jan; 25(1):44-53. PubMed ID: 28129126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
    Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
    Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
    J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the AAVS1 Site by CRISPR/Cas9 with an Inducible Transgene Cassette for the Neuronal Differentiation of Human Pluripotent Stem Cells.
    Gu J; Rollo B; Sumer H; Cromer B
    Methods Mol Biol; 2022; 2495():99-114. PubMed ID: 35696030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration.
    Smith JR; Maguire S; Davis LA; Alexander M; Yang F; Chandran S; ffrench-Constant C; Pedersen RA
    Stem Cells; 2008 Feb; 26(2):496-504. PubMed ID: 18024421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
    Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
    Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Doxycycline-Inducible System for Genetic Correction of iPSC Disease Models.
    Sim X; Cardenas-Diaz FL; French DL; Gadue P
    Methods Mol Biol; 2016; 1353():13-23. PubMed ID: 25630922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfection, selection, and colony-picking of human induced pluripotent stem cells TALEN-targeted with a GFP gene into the AAVS1 safe harbor.
    Cerbini T; Luo Y; Rao MS; Zou J
    J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines.
    Cerbini T; Funahashi R; Luo Y; Liu C; Park K; Rao M; Malik N; Zou J
    PLoS One; 2015; 10(1):e0116032. PubMed ID: 25587899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas-Mediated Knock-in of Genetically Encoded Fluorescent Biosensors into the AAVS1 Locus of Human-Induced Pluripotent Stem Cells.
    Stellon D; Tran MTN; Talbot J; Chear S; Khalid MKNM; Pébay A; Vickers JC; King AE; Hewitt AW; Cook AL
    Methods Mol Biol; 2022; 2549():379-398. PubMed ID: 34505269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
    Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
    Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Genomic Safe Harbors as Target Sites for Stable Expression of the Heterologous Gene in HEK293 Cells.
    Shin S; Kim SH; Shin SW; Grav LM; Pedersen LE; Lee JS; Lee GM
    ACS Synth Biol; 2020 Jun; 9(6):1263-1269. PubMed ID: 32470292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient differentiation of cardiomyocytes and generation of calcium-sensor reporter lines from nonhuman primate iPSCs.
    Lin Y; Liu H; Klein M; Ostrominski J; Hong SG; Yada RC; Chen G; Navarengom K; Schwartzbeck R; San H; Yu ZX; Liu C; Linask K; Beers J; Qiu L; Dunbar CE; Boehm M; Zou J
    Sci Rep; 2018 Apr; 8(1):5907. PubMed ID: 29651156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human induced pluripotent stem cell line with genetically encoded fluorescent voltage indicator generated via CRISPR for action potential assessment post-cardiogenesis.
    Sun YH; Kao HKJ; Chang CW; Merleev A; Overton JL; Pretto D; Yechikov S; Maverakis E; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2020 Jan; 38(1):90-101. PubMed ID: 31566285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients.
    Lepperhof V; Polchynski O; Kruttwig K; Brüggemann C; Neef K; Drey F; Zheng Y; Ackermann JP; Choi YH; Wunderlich TF; Hoehn M; Hescheler J; Sarić T
    PLoS One; 2014; 9(9):e107363. PubMed ID: 25226590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.